Are you over 18 and want to see adult content?
More Annotations
A complete backup of polytechnichub.com
Are you over 18 and want to see adult content?
A complete backup of deine-angelwelt.de
Are you over 18 and want to see adult content?
A complete backup of gold-collagen.com
Are you over 18 and want to see adult content?
A complete backup of elg-asesores.com
Are you over 18 and want to see adult content?
A complete backup of containerdoor.com
Are you over 18 and want to see adult content?
A complete backup of tangerangonline.id
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of howtowriteproposal.org
Are you over 18 and want to see adult content?
A complete backup of festivalofarchives.org
Are you over 18 and want to see adult content?
A complete backup of sigmarepository.org
Are you over 18 and want to see adult content?
A complete backup of headtohealth.gov.au
Are you over 18 and want to see adult content?
A complete backup of ilovepozzodadda.it
Are you over 18 and want to see adult content?
A complete backup of webcourseworld.com
Are you over 18 and want to see adult content?
A complete backup of railroadcity.com
Are you over 18 and want to see adult content?
Text
SARS-COV-2 TEST
60061-7 (2021-01) Accula SARS-CoV-2 IFU 3 process positive and negative controls, enzymes, OscAR™ reagents, and a detection strip necessary for the full completion of the assay. ABOUT US - MESA BIOTECH Dr. Hong Cai co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-basedassays for
SARS-COV-2 TEST
4 • Store reagents at room temperature (15°C - 30°C, 59°F - 86°F). Do not refrigerate or freeze. • o not reuse kit contents Collection Swabs, Test Cassettes, Transfer Pipettes, Control Swabs, orSARS-CoV-2
TEST COMPLETE READ RESULTS 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
FACT CORONAVIRUS SHEET FOR PATIENTS • Where can I go for updates and more information? The most up -to date information on COVID-19 https://www.cdc.gov/is available at the CDC General webpage: COVID19 60060 REV 3 ACCULA SARS-COV-2 QRG 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
FACT SHEET FOR PATIENTS This means that you could possibly still have COVID-19 even though the test result is negative. If your test is negative, your healthcare provider will consider the test ACCULA™ DOCK OPERATOR’S GUIDE 3 VI. Warnings and Precautions Y Do not block the air vents located on the rear and sides of the Accula™ Dock.A minimum of 2 inches (5 cm) of clearance must be maintained. Y Do not place the Accula™ Dock in the vicinity of equipment that generates heat.The Dock must be maintained in an ambient temperature range of 15°C to 30°C (59 to86°F) to
WILLIAM R. BRODY JOINS MESA BIOTECH AS CHAIRMAN OF THE SAN DIEGO, April 6, 2016 – Mesa Biotech Inc., a privately-held, molecular diagnostic company developing a testing platform designed specifically for point-of-care infectious disease diagnosis, today announced that William R. Brody, M.D., Ph.D. has been appointed Mesa Biotech’s Chairman of the Board. As former president of San Diego’s Salk Institute for Biological Studies, Brody ACTIONABLE. ACCESSIBLE. AFFORDABLE. SARS-COV-2 (COVID-19SARS-COV-2ABOUT US The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. Easy and fast, our qualitative, rapid PCR-based test provides visual results within ~ 30 minutes. The Accula SARS-CoV-2 Test has not been FDASARS-COV-2 TEST
60061-7 (2021-01) Accula SARS-CoV-2 IFU 3 process positive and negative controls, enzymes, OscAR™ reagents, and a detection strip necessary for the full completion of the assay. ABOUT US - MESA BIOTECH Dr. Hong Cai co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-basedassays for
SARS-COV-2 TEST
4 • Store reagents at room temperature (15°C - 30°C, 59°F - 86°F). Do not refrigerate or freeze. • o not reuse kit contents Collection Swabs, Test Cassettes, Transfer Pipettes, Control Swabs, orSARS-CoV-2
TEST COMPLETE READ RESULTS 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
FACT CORONAVIRUS SHEET FOR PATIENTS • Where can I go for updates and more information? The most up -to date information on COVID-19 https://www.cdc.gov/is available at the CDC General webpage: COVID19 60060 REV 3 ACCULA SARS-COV-2 QRG 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
FACT SHEET FOR PATIENTS This means that you could possibly still have COVID-19 even though the test result is negative. If your test is negative, your healthcare provider will consider the test ACCULA™ DOCK OPERATOR’S GUIDE 3 VI. Warnings and Precautions Y Do not block the air vents located on the rear and sides of the Accula™ Dock.A minimum of 2 inches (5 cm) of clearance must be maintained. Y Do not place the Accula™ Dock in the vicinity of equipment that generates heat.The Dock must be maintained in an ambient temperature range of 15°C to 30°C (59 to86°F) to
WILLIAM R. BRODY JOINS MESA BIOTECH AS CHAIRMAN OF THE SAN DIEGO, April 6, 2016 – Mesa Biotech Inc., a privately-held, molecular diagnostic company developing a testing platform designed specifically for point-of-care infectious disease diagnosis, today announced that William R. Brody, M.D., Ph.D. has been appointed Mesa Biotech’s Chairman of the Board. As former president of San Diego’s Salk Institute for Biological Studies, BrodySARS-COV-2 TEST
The Accula™ SARS-Cov-2 Test performed on the Accula™ Dock or the Silaris™ Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies for the qualitative, visual detection of the coronavirus SARS-CoV-2 FACT SHEET FOR PATIENTS This means that you could possibly still have COVID-19 even though the test result is negative. If your test is negative, your healthcare provider will consider the test MESA BIOTECH RECEIVES EMERGENCY USE AUTHORIZATION FROM FDA Easy to use, palm-sized system will enable broader use across healthcare facilities closer to the patients and will begin shipping immediately SAN DIEGO, CA – March 24, 2020 – Today, Mesa Biotech announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for its Accula™ SARS-CoV-2Test, which gives
MESA BIOTECH TO RECEIVE FUNDING FROM US HEALTH AND HUMAN Since its inception at Los Alamos National Lab, Mesa Biotech has focused on technology well-suited for emergency defense, near-patient testing and rapid response to pandemics, such as SARS, Ebola and now COVID-19 SAN DIEGO, CA – March 19, 2020 – Mesa Biotech Inc., a privately-held, molecular diagnostic company has developed an affordable, 30 minute sample-to-answer NASAL SAMPLE SELF-COLLECTION GUIDE IVD SARS-CoV-2 Quick Reference Guide EUA Only FOR NASAL SWAB SPECIMENS COV4100 1 Label SARS-CoV-2 Buffer with your name and date. SARS-CoV-2 Buffer Jane Doe March 20, 2020HCP FACT SHEET
Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scriptsSARS-COV-2 BUFFER
NOTE: LOOK CLOSELY WHEN INTERPRETING THE RESULTS!The appearance of any shade of a Blue Test Line at the T position is a valid result that is interpreted as a positive for SARS-CoV-2 viral RNA. A negative result will only contain a Blue IT IS PCR IN THE PALM OF YOUR HAND. It is PCR in the palm of your hand. Accurate, Accessible, Actionable diagnosis for better healthcare Influenza A/B & Respiratory SyncytialVirus (RSV)
FACT SHEET FOR HEALTHCARE PROVIDERS Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts MESA BIOTECH TO DEMONSTRATE NEW MOLECULAR POC TESTING SAN DIEGO – April 18, 2018 – Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced it will demonstrate its novel Accula™ Flu A/Flu B test at the 28th Annual European Congress of Clinical Microbiology ACTIONABLE. ACCESSIBLE. AFFORDABLE. SARS-COV-2 (COVID-19SARS-COV-2ABOUT US The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. Easy and fast, our qualitative, rapid PCR-based test provides visual results within ~ 30 minutes. The Accula SARS-CoV-2 Test has not been FDA ABOUT US - MESA BIOTECH Dr. Hong Cai co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-basedassays for
SARS-COV-2 TEST
60061-7 (2021-01) Accula SARS-CoV-2 IFU 3 process positive and negative controls, enzymes, OscAR™ reagents, and a detection strip necessary for the full completion of the assay.SARS-COV-2 TEST
4 • Store reagents at room temperature (15°C - 30°C, 59°F - 86°F). Do not refrigerate or freeze. • o not reuse kit contents Collection Swabs, Test Cassettes, Transfer Pipettes, Control Swabs, orSARS-CoV-2
FACT CORONAVIRUS SHEET FOR PATIENTS • Where can I go for updates and more information? The most up -to date information on COVID-19 https://www.cdc.gov/is available at the CDC General webpage: COVID19 TEST COMPLETE READ RESULTS 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
60060 REV 3 ACCULA SARS-COV-2 QRG 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
NASAL SAMPLE SELF-COLLECTION GUIDE IVD SARS-CoV-2 Quick Reference Guide EUA Only FOR NASAL SWAB SPECIMENS COV4100 1 Label SARS-CoV-2 Buffer with your name and date. SARS-CoV-2 Buffer Jane Doe March 20, 2020 FACT SHEET FOR HEALTHCARE PROVIDERS Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts WILLIAM R. BRODY JOINS MESA BIOTECH AS CHAIRMAN OF THE SAN DIEGO, April 6, 2016 – Mesa Biotech Inc., a privately-held, molecular diagnostic company developing a testing platform designed specifically for point-of-care infectious disease diagnosis, today announced that William R. Brody, M.D., Ph.D. has been appointed Mesa Biotech’s Chairman of the Board. As former president of San Diego’s Salk Institute for Biological Studies, Brody ACTIONABLE. ACCESSIBLE. AFFORDABLE. SARS-COV-2 (COVID-19SARS-COV-2ABOUT US The Accula System has received FDA Emergency Use Authorization (EUA) for SARS-CoV-2 (the virus responsible for COVID-19) in vitro diagnostic testing. It is available now for use in patient care settings. Easy and fast, our qualitative, rapid PCR-based test provides visual results within ~ 30 minutes. The Accula SARS-CoV-2 Test has not been FDA ABOUT US - MESA BIOTECH Dr. Hong Cai co-founded the business in 2009. She has more than 20 years of experience in the field of molecular biology and is the inventor of the technology used in Mesa Biotech’s platform. She spent 13 years as a principal investigator at Los Alamos National Laboratory, managing and leading projects for nucleic acid-basedassays for
SARS-COV-2 TEST
60061-7 (2021-01) Accula SARS-CoV-2 IFU 3 process positive and negative controls, enzymes, OscAR™ reagents, and a detection strip necessary for the full completion of the assay.SARS-COV-2 TEST
4 • Store reagents at room temperature (15°C - 30°C, 59°F - 86°F). Do not refrigerate or freeze. • o not reuse kit contents Collection Swabs, Test Cassettes, Transfer Pipettes, Control Swabs, orSARS-CoV-2
FACT CORONAVIRUS SHEET FOR PATIENTS • Where can I go for updates and more information? The most up -to date information on COVID-19 https://www.cdc.gov/is available at the CDC General webpage: COVID19 TEST COMPLETE READ RESULTS 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
60060 REV 3 ACCULA SARS-COV-2 QRG 60060-3 (2020-07) Mesa Biotech, INC. 6190 Cornerstone Court East Suite 220 San Diego, CA 92121, USA www.mesabiotech.com D. INTERPRETATION OFRESULTS
NASAL SAMPLE SELF-COLLECTION GUIDE IVD SARS-CoV-2 Quick Reference Guide EUA Only FOR NASAL SWAB SPECIMENS COV4100 1 Label SARS-CoV-2 Buffer with your name and date. SARS-CoV-2 Buffer Jane Doe March 20, 2020 FACT SHEET FOR HEALTHCARE PROVIDERS Report Adverse events, including problems with test performance or results, to MedWatch by submitting the online FDA Form 3500 (https://www.accessdata.fda.gov/scripts WILLIAM R. BRODY JOINS MESA BIOTECH AS CHAIRMAN OF THE SAN DIEGO, April 6, 2016 – Mesa Biotech Inc., a privately-held, molecular diagnostic company developing a testing platform designed specifically for point-of-care infectious disease diagnosis, today announced that William R. Brody, M.D., Ph.D. has been appointed Mesa Biotech’s Chairman of the Board. As former president of San Diego’s Salk Institute for Biological Studies, BrodySARS-COV-2 TEST
4 • Store reagents at room temperature (15°C - 30°C, 59°F - 86°F). Do not refrigerate or freeze. • o not reuse kit contents Collection Swabs, Test Cassettes, Transfer Pipettes, Control Swabs, orSARS-CoV-2
MESASURE DEMO
GET IN TOUCH +1 (858) 800-4929 SAN DIEGO, CA. Copyright © 2020 Mesa Biotech. NASAL SAMPLE SELF-COLLECTION GUIDE IVD SARS-CoV-2 Quick Reference Guide EUA Only FOR NASAL SWAB SPECIMENS COV4100 1 Label SARS-CoV-2 Buffer with your name and date. SARS-CoV-2 Buffer Jane Doe March 20, 2020 FACT SHEET FOR PATIENTS This means that you could possibly still have COVID-19 even though the test result is negative. If your test is negative, your healthcare provider will consider the test MESA BIOTECH TO RECEIVE FUNDING FROM US HEALTH AND HUMAN Since its inception at Los Alamos National Lab, Mesa Biotech has focused on technology well-suited for emergency defense, near-patient testing and rapid response to pandemics, such as SARS, Ebola and now COVID-19 SAN DIEGO, CA – March 19, 2020 – Mesa Biotech Inc., a privately-held, molecular diagnostic company has developed an affordable, 30 minute sample-to-answer MESA BIOTECH TO RECEIVE UP TO $15.4 MILLION FUNDING FROM Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative. SAN DIEGO, CA – July 31, 2020 –Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases diagnosis, today announced it has been awarded a contract up to $15.4 million from the National Institutes of Health’s (NIH) Rapid Acceleration of MESA BIOTECH ANNOUNCES INGO CHAKRAVARTY AS PRESIDENT AND SAN DIEGO, CA – April 15, 2020 – The Board of Directors of Mesa Biotech, announced today the appointment of Ingo Chakravarty as President and Chief Executive Officer (CEO), effective immediately.. Mr. Chakravarty succeeds Dr. Hong Cai, Co-Founder and CEO of Mesa Biotech since 2010. Dr. Cai will remain actively involved with the company in her new role as Chief Technology Officer.SARS-COV-2 BUFFER
NOTE: LOOK CLOSELY WHEN INTERPRETING THE RESULTS!The appearance of any shade of a Blue Test Line at the T position is a valid result that is interpreted as a positive for SARS-CoV-2 viral RNA. A negative result will only contain a Blue SEKISUI DIAGNOSTICS ENTERS STRATEGIC ALLIANCE WITH MESA Sekisui Diagnostics becomes exclusive distributor for Mesa Biotech products in the U.S. and Canada Strategic alliance expands Sekisui Diagnostics’ portfolio and facilitates entry into the molecular point-of-care (POC) market starting with Flu A/Flu B test (pending FDA clearance) followed by additional upper respiratory infectious disease assays Mesa Biotech products will have immediate MESA BIOTECH PROVIDES CORPORATE UPDATE Company Commercializes Accula™ System in EU and U.S. and Prepares for Expansion SAN DIEGO, CA – July 26, 2018 – Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, provides an update onNo results found.
_ _ 858-800-4929
Home
About
Company & LeadershipDistribution
Technology
Products
COVID-19
News & Media
Careers
Contact Us
Home
About
Company & LeadershipDistribution
Technology
Products
COVID-19
News & Media
Careers
Contact Us
Accula SARS-CoV-2 Test has received FDA Emergency Use AuthorizationOur COVID-19 Test
Simplifying PCR, transforming healthcare.Our Product
Accurate. Accessible. Actionable.About Mesa Biotech
POINT-OF-CARE MOLECULAR SYSTEM MESA BIOTECH LAUNCHING ACCULA SARS-COV-2 TESTOur COVID-19 Test
\n","url":"https://www.youtube.com/watch?v=GZzHt-mdDCI","width":854,"height":480,"providerName":"YouTube","thumbnailUrl":"https://i.ytimg.com/vi/GZzHt-mdDCI/hqdefault.jpg","resolvedBy":"youtube"}" data-block-type="32" id="block-yui_3_17_2_1_1564077216537_17300"> " data-provider-name="YouTube" id="yui_3_17_2_1_1586136300795_112"> _LET US SHOW YOU SOMETHING YOU’VE NEVER SEEN BEFORE…_Our Technology
-------------------------COLLECT
SIMPLE NASAL SWAB SPECIMEN COLLECTION.LOAD & RUN
DISPENSE THE BUFFER INTO THE CASSETTE, CLOSE THE DOCK LID AND WALKAWAY.
READ
WHEN NOTIFIED BY THE DOCK, REMOVE THE CASSETTE AND READ THE TESTRESULTS.
Our Product
------------------------- THE KEY TO OUR SUCCESS IS OUR TEAM OF DEDICATED AND TALENTED EMPLOYEES, EMPLOYEES THAT ARE DRIVEN TO DELIVER NOVEL, QUALITY DIAGNOSTIC PRODUCTS.Our Company
Back to Top
GET IN TOUCH
info@mesabiotech.com+1 (858) 800-4929
San Diego, CA 92121
QUICK LINKS
*
Home
*
Company
*
Products
*
Technology
*
Careers
*
News & Media
INQUIRY FORM
Name *
First Name
Last Name
Email * Phone
(###)
###
####
Message *
Thank you!
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0